Jiangsu Nanfang Medical Co., Ltd.SSE: 603880

(603880)"Jiangsu Nanfang Medical Co., Ltd."Report for Q3 2026

· Issued by Jiangsu Nanfang Medical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603880 · · 12 pages · Chinese

Summary by 6ix AI

The report indicates a decline in revenue and net profit compared to the previous year, with significant losses reported for the quarter. It also highlights the company's total assets and shareholders' equity, showing a decrease from the previous year-end figures. The report assures the accuracy and completeness of the financial information presented, with no audit conducted for this quarter.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Jiangsu Nanfang Medical Co., Ltd. on 6ix

Earlier from Jiangsu Nanfang Medical

Later from Jiangsu Nanfang Medical

All Jiangsu Nanfang Medical news releases